DENTSPLY SIRONA Inc. $XRAY Shares Purchased by Prudential Financial Inc.

Prudential Financial Inc. raised its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 67.9% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,158,415 shares of the medical instruments supplier’s stock after purchasing an additional 468,415 shares during the quarter. Prudential Financial Inc.’s holdings in DENTSPLY SIRONA were worth $18,396,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in XRAY. Vanguard Group Inc. increased its holdings in shares of DENTSPLY SIRONA by 2.8% in the first quarter. Vanguard Group Inc. now owns 20,740,589 shares of the medical instruments supplier’s stock valued at $309,864,000 after purchasing an additional 557,329 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in shares of DENTSPLY SIRONA by 11.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 13,961,759 shares of the medical instruments supplier’s stock worth $208,590,000 after purchasing an additional 1,412,517 shares during the period. Fuller & Thaler Asset Management Inc. grew its position in DENTSPLY SIRONA by 4.7% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 12,077,949 shares of the medical instruments supplier’s stock valued at $180,445,000 after buying an additional 538,531 shares during the last quarter. AQR Capital Management LLC increased its stake in DENTSPLY SIRONA by 119.4% in the 1st quarter. AQR Capital Management LLC now owns 6,346,685 shares of the medical instruments supplier’s stock valued at $93,423,000 after buying an additional 3,453,662 shares during the period. Finally, Edmond DE Rothschild Holding S.A. raised its position in DENTSPLY SIRONA by 26.4% during the 1st quarter. Edmond DE Rothschild Holding S.A. now owns 2,913,400 shares of the medical instruments supplier’s stock worth $43,526,000 after buying an additional 609,300 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

Analyst Upgrades and Downgrades

XRAY has been the topic of several analyst reports. Barrington Research lowered their target price on shares of DENTSPLY SIRONA from $18.00 to $14.00 and set an “outperform” rating on the stock in a report on Monday, November 10th. Zacks Research lowered DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a report on Monday, November 10th. Mizuho set a $13.00 target price on DENTSPLY SIRONA in a research report on Friday, November 7th. Evercore ISI reduced their price target on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating for the company in a report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. decreased their price target on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a research note on Friday, November 7th. Two research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $16.08.

DENTSPLY SIRONA Trading Up 1.8%

Shares of DENTSPLY SIRONA stock opened at $11.29 on Thursday. The company has a 50-day moving average of $12.13 and a two-hundred day moving average of $14.17. DENTSPLY SIRONA Inc. has a 12-month low of $9.85 and a 12-month high of $20.59. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13. The stock has a market cap of $2.25 billion, a PE ratio of -2.38, a price-to-earnings-growth ratio of 0.81 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.08). DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The firm had revenue of $904.00 million during the quarter, compared to analyst estimates of $900.33 million. During the same quarter in the prior year, the company earned $0.50 EPS. The business’s revenue was down 4.9% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. On average, research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.